✦ LIBER ✦

A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis

✍ Scribed by C. W. Imrie; I. S. Benjamin; J. C. Ferguson; A. J. McKay; I. Mackenzie; J. O'Neill; L. H. Blumgart

Publisher: John Wiley and Sons
Year: 1978
Tongue: English
Weight: 524 KB
Volume: 65
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800650514

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A controlled trial of Trasylol in the tr

A controlled trial of Trasylol in the treatment of acute pancreatitis

✍ John E. Trapnell; C. C. Rigby; C. H. Talbot; E. H. L. Duncan 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

Randomized, double-blind phase II trial

Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis

✍ Mr A. N. Kingsnorth; S. W. Galloway; L. J. Formela 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 763 KB

High-Dose intraperitoneal aprotinin trea

High-Dose intraperitoneal aprotinin treatment of acute severe pancreatitis: A double-blind randomized multi-center trial

✍ Rikard Berling; Sven Genell; Kjell Ohlsson 📂 Article 📅 1994 🏛 Springer Japan 🌐 English ⚖ 641 KB

Multicentre clinical trial of low volume

Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitis

✍ Mr. T. Leese; M. Holliday; D. Heath; A. W. Hall; P. R. F. Bell 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 556 KB

Sodium benzoate in the treatment of acut

Sodium benzoate in the treatment of acute hepatic encephalopathy: A double-blind randomized trial

✍ S. Sushma; S. Dasarathy; Dr. Rakesh K. Tandon; Satish Jain; Surya Gupta; Mahende 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 842 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

✍ Burton Combes; Robert L. Carithers Jr.; Willis C. Maddrey; Danyu Lin; Dr Mary F. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 792 KB

One hundred fifty-one patients with primary biliary cirrhosis (PBC) grouped into four strata based on entry serum bilirubin (<2 mg/dL vs. 2 mg/dL or greater) and liver histology (stages I, 1 1 vs. stages 111, IV-Ludwig criteria) were randomized within each stratum to ursodiol or placebo given in a s